HOOKIPA Pharma (HOOK) 10-Q2024 Q2 Quarterly report

Filed: 8 Aug 24, 5:15pm

Content analysis

Positive
Negative
Uncertain
Constraining
Legalese
Litigous
Readability	H.S. senior Avg

New words: AgreementSM, Aldag, alive, alleviate, alleviated, analyzing, appointed, appointment, automatically, award, Cassidy, chair, challenging, Coelho, column, competition, counteract, covering, CPS, CR, curtail, cutoff, deceased, decline, director, doubt, Eastern, encouraging, environment, equivalent, formal, fractional, garden, grow, harm, health, hinder, hold, impede, insufficient, intense, Joern, join, Kandera, leadership, leave, Leerink, lieu, likelihood, lucrative, median, methodology, mitigate, mitigating, OS, par, person, PFS, pharmaceutical, pivotal, Policy, population, President, PRIME, proportional, proportionate, proportionately, prospective, pursuit, RECIST, Reinhard, replacement, resigned, retired, retroactive, retroactively, reverse, satisfaction, Sean, Secretary, skilled, split, stockholder, subgroup, subset, succeeding, Terry, thereto, training, turnover, unchanged, uniformly, unreached, unrecognized, Vice

Removed: Careful, degree, doubling, expansion, forced, partnered, reach, SVB

Search this filing

Filing tables

Export all tables to Excel

Filing exhibits

Related press release

HOOK similar filings

Filing view

Default size S M L
Default font Times Arial

External links

Share this filing

Exhibit 32.1

CERTIFICATION PURSUANT TO

18 U.S.C. SECTION 1350, AS ADOPTED PURSUANT TO

SECTION 906 OF THE SARBANES-OXLEY ACT OF 2002

In connection with the Quarterly Report of HOOKIPA Pharma Inc. (the “Company”) on Form 10-Q for the quarterly period ended June 30, 2024 as filed with the Securities and Exchange Commission on the date hereof (the “Report”), each of the undersigned officers hereby certifies, pursuant to 18 U.S.C. Section 1350, as adopted pursuant to Section 906 of the Sarbanes-Oxley Act of 2002, that to the best of their knowledge:

(1) the Report fully complies with the requirements of Section 13(a) or 15(d) of the Securities Exchange Act of 1934; and

(2) the information contained in the Report fairly presents, in all material respects, the financial condition and results of operations of the Company.


Dated: August 8, 2024	/s/ Malte Peters

	Malte Peters
	Chief Executive Officer
	(Principal Executive Officer)

Dated: August 8, 2024	/s/ Terry Coelho

	Terry Coelho
	Executive Vice President and Chief Financial Officer
	(Principal Financial and Accounting Officer)

We use cookies on this site to provide a more responsive and personalized service. Continuing to browse, clicking I Agree, or closing this banner indicates agreement. See our Cookie Policy for more information.